Cutting-edge human milk-derived therapy: a revolutionary approach in treating blood cancers

The therapy, combining human milk oligosaccharides (HMOs) and a specific gut bacteria strain, represents not only a scientific breakthrough but also holds substantial economic implications.

How sugar changes the metabolism of cavity-causing bacteria

The findings suggest that lysine lactylation contributes to metabolic regulation in bacteria and that GNAT13 may limit sucrose-driven biofilm formation.

How Akkermansia and Lactobacillus plantarum could revolutionize treatment for Lupus through immune regulation

This study demonstrated fundamental mechanisms through which A. muciniphila and L. plantarum modify the gut microbiota and control immune responses in the SLE mouse model.

The cutting-edge potential of Microbial Therapeutics in microbiome modulation

Gianluca Ianiro, from Gemelli Hospital in Rome, discusses the future of microbiota modulation, with a focus on Microbial Therapeutics.

Introducing Gumtastic: SynBalance’s probiotic solution for Oral Care

Smiling ear to ear, supporting healthy teeth and mouth.

The respiratory microbiota could contribute to determine the severity of pneumonia

The findings suggest that the interplay between the respiratory tract microbiota, the levels of bacterial pathogens and specific clinical interventions is a key factor in determining the outcome of bacterial…

The mouth microbiota may forecast the recurrence of oral cancer

The findings of a recent study suggest that the composition of the mouth microbiota can be used to predict the recurrence of oral cancer.

Canada endorses groundbreaking gut-brain health claims for Chr. Hansen’s probiotic strain

This approval marks a significant leap forward in our understanding of holistic health and the intricate connection between our guts and our brains.

Probiotics and clinical practice

Francisco Guarner, from Centro Médico Teknon (Barcelona, Spain), talks about the recent update of the WGO’s Probiotics and prebiotics guidelines.

Probiotics regulation in Europe: when lack of harmonization undermines both consumers and the industry

In Europe the probiotics sector is facing a lack of harmonization and a near-total veto on any health claims. What happened, where are we now, and what can we hope…

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top